Skip to main content
TipRanks
Go Ultimate75% OFF

Philippe Perron Savard Insider Profile

4 Followers

Philippe Perron Savard, former Vice-President & General Counsel at Acerus Pharmaceuticals, holds 47.20K shares in Acerus Pharmaceuticals (Ticker: ASPCQ). Most recently, Philippe Perron Savard Bought 14,200 shares of Acerus Pharmaceuticals on Dec 08, 2018 for an estimated value of $1.92K.

Philippe Perron Savard's Trading History

ASPCQ
Acerus Pharmaceuticals
Dec 08, 2018―Informative Buy1.92K$10.34K
ASPCQ
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 08, 2018Informative BuyC$1.92K14,200C$0.14-34.90%―
Nov 16, 2017Informative BuyC$4.95K33,000C$0.15-3.90%―

You May Also Like

Philippe Perron Savard insider profile FAQ

What is the percentage of profitable transactions made by Philippe Perron Savard?
The percentage of profitable transactions made by Philippe Perron Savard is 0%.
What is the average return per transaction made by Philippe Perron Savard?
The average return per transaction made by Philippe Perron Savard is -19.40%.
What stocks does Philippe Perron Savard hold?
Philippe Perron Savard holds: ASPCQ stocks.
What was Philippe Perron Savard’s latest transaction?
Philippe Perron Savard’s latest transaction was an Informative Buy of $1.92K.
What was Philippe Perron Savard's most profitable transaction?
Philippe Perron Savard’s most profitable transaction was an Informative Buy of ASPCQ stock on November 16, 2017. The return on the trade was -3.90%.
What is Philippe Perron Savard's role in Acerus Pharmaceuticals?
Philippe Perron Savard's role in Acerus Pharmaceuticals is Vice-President & General Counsel.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.